In vitro and in vivo genotoxic effects of differently sized amorphous SiO 2 nanomaterials were investigated. In the alkaline Comet assay (with V79 cells), non-cytotoxic concentrations of 300 and 100-300 g/mL 15 nm-SiO 2 and 55 nm-SiO 2 , respectively, relevant (at least 2-fold relative to the negative control) DNA damage. In the Alkaline unwinding assay (with V79 cells), only 15 nm-SiO 2 significantly increased DNA strand breaks (and only at 100 g/mL), whereas neither nanomaterial (up to 300 g/mL) increased Fpg (Formamidopyrimidine DNA glycosylase)-sensitive sites reflecting oxidative DNA base modifications. In the Comet assay using rat precision-cut lung slices, 15 nm-SiO 2 and 55 nm-SiO 2 induced significant DNA damage at ≥100 g/mL. In the Alkaline unwinding assay (with A549 cells), 30 nm-SiO 2 and 55 nm-SiO 2 (with larger primary particle size (PPS)) induced significant increases in DNA strand breaks at ≥50 g/mL, whereas 9 nm-SiO 2 and 15 nm-SiO 2 (with smaller PPS) induced significant DNA damage at higher concentrations. These two amorphous SiO 2 also increased Fpg-sensitive sites (significant at 100 g/mL). In vivo, within 3 days after single intratracheal instillation of 360 g, neither 15 nm-SiO 2 nor 55 nm-SiO 2 caused genotoxic effects in the rat lung or in the bone marrow. However, pulmonary inflammation was observed in both test groups with findings being more pronounced upon treatment with 15 nm-SiO 2 than with 55 nm-SiO 2 . Taken together, the study shows that colloidal amorphous SiO 2 with different particle sizes may induce genotoxic effects in lung cells in vitro at comparatively high concentrations. However, the same materials elicited no genotoxic effects in the rat lung even though pronounced pulmonary inflammation evolved. This may be explained by the fact that a considerably lower dose reached the target cells in vivo than in vitro. Additionally, the different time points of investigation may provide more time for DNA damage repair after instillation.
Introduction
Amorphous SiO 2 nanoparticles have gained commercial importance as additives to cement, paint, cosmetics or food, and they are also used in the medical sector, e.g. as drug delivery devices [1] [2] [3] . Synthetic amorphous SiO 2 may either be produced by wet species; SD, standard deviation; SIMS, secondary ion mass spectrometry; STIS, shortterm inhalation study; TG, test guideline; XPS, X-ray photoelectron spectroscopy; XRD, X-ray diffusion.
process (colloidal sol, gel, or precipitated SiO 2 ) or pyrolytic synthesis (fumed SiO 2 ) [1, [4] [5] [6] [7] . As compared to crystalline SiO 2 (e.g. quartz dusts), amorphous SiO 2 is reported being of low toxicity [1, 6] . Nevertheless, along with their increasing prevalence in the occupational and consumer contexts, the potential adverse impacts of nanotechnological products containing amorphous SiO 2 nanoparticles to humans and the environment need to be addressed.
Generally, inhalation is an important route of uptake for nanomaterials (NMs) [8] [9] [10] . Depending on their size and the degree of agglomeration in the aerosol preparations, airborne NMs may pass the upper respiratory tract and deposit in the alveolar region of the lung [10] [11] [12] . If the pulmonary clearance mechanism is overloaded, nanoparticles may accumulate in the lung. As a result, inflammation and epithelial cell proliferation, followed by fibrosis, emphysema and, possibly, tumors may develop [9, 10, [13] [14] [15] .
Due to their higher surface area, nanoparticles may induce the generation of more free radicals and reactive oxygen species (ROS) than their non-nanoform chemical counterparts [1, 16] . Since ROS may specifically react with cellular proteins or the DNA, NMs may elicit genotoxic effects, also in the cells of the respiratory tract, the primary site of contact upon inhalation [17] [18] [19] [20] [21] [22] . In ROS-induced oxidative DNA damage, NMs do not physically interact with the nuclear DNA. However, NMs may also induce genotoxicity by direct interaction with the DNA [20, 23, 24] .
The number of publications addressing in vitro cytotoxic effects of amorphous SiO 2 nanoparticles is continuously increasing [25] . These studies report on different degrees of inflammation, oxidative stress or cytotoxic reactions found in vitro using human or rodent pulmonary cells when addressing respiratory tract effects [1, 20, [25] [26] [27] . By contrast, comparably few in vitro studies are available evaluating the genotoxic potential of amorphous SiO 2 nanoparticles, and their results at non-cytotoxic concentrations are inconsistent [20, [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] . The available in vitro studies used a broad variety of different SiO 2 NMs, test systems, exposure conditions and genotoxicity assays.
Even fewer in vivo studies have addressed the genotoxic potential of amorphous SiO 2 NMs in the rodent lung [32, 39, [41] [42] [43] [44] [45] [46] and none of them revealed significant genotoxicity. Also in these animal studies, different types of amorphous SiO 2 , different methods of substance preparation and characterization (if reported), as well as different animal species and exposure protocols, and genotoxicity assays were applied.
Overall, the in vitro or in vivo micronucleus and Comet assays are the most frequently used tests to investigate NM genotoxicity [24, 36, 47] . Nevertheless, due to the lack of standardization of test method performance and the broad variety of different types of SiO 2 NMs tested, it is still difficult, if not impossible, to draw a final conclusion on genotoxicity of amorphous SiO 2 NMs.
Further, it remains unclear whether nanoparticle size affects the outcome of genotoxicity studies. Generally, the greater surface area per mass of smaller-sized NMs is expected to increase their biological activity as compared to micron-scale substances of the same chemical composition [48] [49] [50] [51] [52] [53] . Since NMs may produce comparatively more ROS than larger particles, it might be suspected that NMs have a greater genotoxic hazard than their micron size counterparts [20] . However, to date, there is no compelling evidence that such a correlation exists [53] .
Against this background, the present survey aimed at investigating the in vitro and in vivo genotoxic potential of differently sized amorphous SiO 2 NMs from the Levasil ® product group. These SiO 2 NMs are colloidal dispersions of amorphous SiO 2 synthesized by means of a growth process from an aqueous solution with dissociated molecular silicic acid [54] . In vitro genotoxicity of Levasil ® 50 and Levasil ® 200 (in the following: 55 nm-SiO 2 and 15 nmSiO 2 , respectively) was investigated in the alkaline Comet assay conducted with V79 Chinese hamster pulmonary fibroblasts cells or rat precision-cut lung slices (PCLuS). The PCLuS test system was included to investigate whether a three-dimensional organderived test system with largely intact pulmonary tissue structure provides an added value for predicting in vivo NM genotoxicity as compared to monolayer cell cultures. (Of note, whereas the Levasil ® numberings refer to the materials' specific surface area, the 15 nm-SiO 2 terms, etc., reflect the primary particle size (PPS) of the materials. Hence, larger Levasil ® numberings correspond to smaller PPS.)
Additionally, the in vitro Alkaline unwinding assay was performed with 15 nm-SiO 2 and 55 nm-SiO 2 in V79 cells and with 15 nm-SiO 2 and 55 nm-SiO 2 as well as with Levasil ® 100 and Levasil ® 300 (in the following: 30 nm-SiO 2 and 9 nm-SiO 2 , respectively) in A549 human alveolar epithelial cells. In this assay, the specific DNA repair enzyme formamidopyrimidine DNA glycosylase (Fpg) has been included, enabling the quantification of DNA strand breaks as well as DNA base modifications recognized by this enzyme, predominantly 8-oxoguanine in case of oxidatively damaged DNA [55] .
For NM test substances, the in vitro effective dose, i.e. the proportion of the applied amount of NMs that will reach the cultured cells or tissues within the given exposure time, is dependent upon the specific diffusion and sedimentation properties of the given NM. These are dependent upon the material properties of the given NMs as well as on the selected cell culture media, supplements and dispersing agents. Therefore, the in vitro effective dosage has to be determined on a case-by-case basis and compared to in vivo dosages to enable assessing the biological relevance of the outcome of in vitro assays [25, [56] [57] [58] [59] . Also the EU NANOGENOTOX joint action highlighted that the evaluation of data obtained in in vitro genotoxicity assays should take into consideration in which proportion applied NMs are likely to reach the test system within the given exposure period [60] . In the present study, the in vitro effective dose of the applied 15 nm-SiO 2 and 55 nm-SiO 2 preparations was calculated using the 'In Vitro Sedimentation, Diffusion, and Dosimetry' (ISDD) model of solution particokinetics for noninteracting spherical particles and their agglomerates in monolayer cell culture systems [57] .
For in vivo genotoxicity testing, the alkaline Comet and micronucleus assays were combined with rat intratracheal instillation studies. During instillation studies, test substances are applied to the animals' lungs under anesthesia as bolus dispersions. Smaller amounts of the test material are required than for inhalation studies, and the application procedure is more convenient than in inhalation studies [61, 62] . Additionally, bronchoalveolar lavage fluid (BALF) and blood were collected for clinical pathology to reveal possible substance-induced inflammatory effects, and all major organs were submitted to gross necropsy and histopathology.
Finally, by selecting differently sized NMs of the same core material Levasil ® , i.e. 9 nm-SiO 2 , 15 nm-SiO 2 , 30 nm-SiO 2 , and 55 nm-SiO 2 , it was a further aim of the present study to assess whether variants of the same SiO 2 NM would exhibit different genotoxic potentials and if so, whether they could be related to a specific material property.
Material and methods
2.1. Material, test substance preparation and characterization, negative and positive controls 2.1.
Material
Unless otherwise stated, all chemicals, reagents and cell culture media were purchased from Sigma-Aldrich (Deisenhofen, Germany) or Biochrom AG (Berlin, Germany). 9 nm-SiO 2 , 15 nmSiO 2 , 30 nm-SiO 2 , and 55 nm-SiO 2 were supplied as 30% 40%, 45%, and 50%, suspensions, respectively, by AkzoNobel AB (Bohus, Sweden). 15 nm-SiO 2 and 55 nm-SiO 2 were tested in all assays. Additionally, 9 nm-SiO 2 and 30 nm-SiO 2 were submitted to the Alkaline unwinding assay using A549 cells and the concomitant colony forming assay.
Test substance preparation
Test substance stock dispersions were prepared daily before the respective experiments as described by Ma-Hock et al. [63] and Landsiedel et al. [64] .
For the in vitro Comet assays, the NM suspensions were first dispersed in fetal calf serum (FCS). Homogenous particle distribution was achieved by stirring at room temperature for 24 h (1000 rpm). The resulting dispersion was mixed with (10/90 v/v; cf. Section 2.2) Minimal Essential Medium (MEM) for the test runs with V79 cells and with Dulbecco's Modified Eagle Medium/Nutrient Mixture F-12 (DMEM/F-12) for the test runs with rat PCLuS. Test substance concentrations of 0, 10, 50, 100, 300, and 600 g/mL were prepared. After incubating the V79 cells or PCLuS with the amorphous SiO 2 NM preparations, it was impossible to remove all particles. The resulting nanoparticle agglomerates created high background values that precluded evaluation of concentrations exceeding 600 g/mL (data not shown).
For the in vitro Alkaline unwinding assays, the NM suspensions were dispersed using the two-step protocol described by Semisch et al. [65] . Briefly, aliquots of NM suspensions were first added to stirring dispersion medium (DMEM and MEM for A549 and V79 cells, respectively) for 1 h. This dispersion was diluted to final working concentrations of 0, 10, 50, 100 and 300 g/mL and stirred for 24 h prior to use.
For the in vivo rat intratracheal instillation studies, NM dispersions were prepared with 0.9% saline (NaCl) to achieve a final bolus dose of 360 g in 500 L.
Test substance characterization
In Table 1 , details of the primary particle characterization and the particle size distribution in protein-free F-12K medium are recorded for all four test substances. For 15 nm-SiO 2 and 55 nmSiO 2 , additionally particle size distribution of dispersions in water, different protein-containing culture media, or 0.9% NaCl solution were determined by analytical ultracentrifugation (AUC) or dynamic light scattering (DLS) as described by Wohlleben [54] and Wohlleben et al. [66] . The state of agglomeration in the different dispersions was assessed by the ratio of the volume-based median particle size to the primary particle size (PPS) [66] . Furthermore, surface chemistry and zeta-potential were assessed for 15 nm-SiO 2 and 55 nm-SiO 2 and surface reactivity and surface ROS generation for 15 nm-SiO 2 (Table 1) [67].
Negative and positive controls
The respective vehicles used in the different assays were applied as negative controls (NC). In the in vitro alkaline Comet assay the alkylating agent ethyl methanesulfonate (EMS; CAS No. 62-50-0) was selected as positive control (PC) and applied at 200 g/mL.
In the in vitro Alkaline unwinding assay, hydrogen peroxide was tested as PC at different concentrations (cf. Supplementary information Fig. SI1 ). In the in vivo studies, five PC animals were treated with 300 mg/kg body weight (bw) EMS dissolved in physiological saline by single oral gavage administration (10 mL/kg bw) and euthanized 24 h after substance exposure.
2.2.
In vitro assays 2.2.1. Alkaline Comet assay in the V79 cell test system 2.2.1.1. Cell preparation, test substance exposure and cytotoxicity testing. The alkaline Comet assay, that allows detecting DNA single and double-strand breaks and alkaline labile DNA sites, was performed with V79 cells treated with up to 600 g/mL 15 nmSiO 2 or 55 nm-SiO 2 as previously described [68] [69] [70] . The V79 cells (in-house inventory) were grown as monolayers in culture dishes in MEM supplemented with l-glutamine (1%, v/v), 1% penicillin/streptomycin (10.000 IU/10.000 mg/mL), and FCS (10%, v/v; in the following: MEM + FCS). The cell cultures were incubated at 37 • C with 5% CO 2 in air and 95% humidity (standard cell culture conditions). During logarithmic growth phase, 1.5 × 10 5 cells were seeded onto 6-well plates, cultivated overnight and then treated with the test substance incubation mixture for 24 h. Afterwards, the cells were washed with phosphate buffered saline (PBS). Single cell suspensions were prepared by trypsin dissociation, collected in MEM + FCS, and placed on ice for immediate use in the experiments.
Cytotoxicity and integrity of suspended cells were determined in the trypan blue exclusion assay. Briefly, one part of the cell suspension was mixed with freshly prepared trypan blue solution (1:1, v/v), and viability was evaluated by light microscopy. Cell suspensions were considered to be of adequate quality (for use in the in vitro alkaline Comet assays) if cell viability exceeded 70% (relative to the total number of counted cells) for V79 cells and 60% for PCLuS cells. Genotoxicity values that coincided with ≤80% cell viability relative to the NC were excluded from the evaluation [20, 36, 64, 71] .
2.2.1.2. Single-cell gel electrophoresis. The single-cell gel electrophoresis was carried out under alkaline conditions as previously published [68, 69] : microscopic slides were pre-coated with normal melting agarose (1% (v/v; SeaKem ® LE; Lonza Rockland, ME, USA) in Ca 2+ -and Mg 2+ -containing PBS. 10 L single cell suspension (1-3 × 10 4 viable cells per slide and up to 6 slides per test group or animal) and 90 L low melting agarose (0.7% (v/v; SeaPlaque ® GTG ® ; Lonza Rockland, ME, USA) in PBS with Ca 2+ and Mg 2+ ) were gently mixed and added to the pre-coated slides, covered with a coverslip until gel polymerization.
All following steps were performed sheltered from UV light and on ice to prevent additional DNA damage: the slides were stored overnight at 4 • C in lysis buffer for removal of cell membranes, cytoplasm, etc., leaving only the nuclei (2.5 M NaCl, 100 mM EDTA, 10 mM Tris, 10% DMSO, 1% Triton ® X-100; pH 10). The slides were placed in an alkaline buffer (300 mM NaOH, 1 mM EDTA; pH ≥ 13) for DNA unwinding (45 min). Electrophoresis was performed in alkaline buffer for 30 min at 25 V (0.85 V/cm) and 300 mA allowing for DNA fragments to migrate away from the nucleus forming a comet-like shape. After neutralization for 10 min in 0.4 M Tris Buffer (pH 7.5), the slides were briefly dehydrated with pure ethanol, air-dried and stored at room temperature until scoring.
2.2.1.3. Evaluation of DNA damage. The DNA on the slides (stained with 40 L ethidium bromide) was evaluated by fluorescence microscopy (Zeiss Axioplan 2, Jena, Germany; 40× objective). Comet images were evaluated and scored with a charge-coupled device (CCD) camera by image analysis using the Comet Assay IV TM (Perceptive Instruments Ltd., Suffolk, UK). The intensity of the comet tail relative to the head was determined, reflecting DNA strand break frequency and the size of the resulting fragments or loops [72, 73] . Highly damaged cells, i.e. 'hedgehog' images, indicating severe genotoxicity, necrosis or apoptosis, were excluded from evaluation.
Two test runs were conducted in the Comet assay using V79 cells or PCLuS cell suspensions. Fifty images on up to four slides per concentration were analyzed in each test run. Results are expressed as the mean and standard deviations of all scored slides per test substance concentration. The Student's t-test (p ≤ 0.05) and regression trend analysis were performed to assess statistical significance. Positive results were considered to be biologically relevant if the corresponding NC value was exceeded by a factor of 2 or more and if effects were dose-dependent.
Alkaline Comet assay in the PCLuS test system
The PCLuS were prepared from female Wistar Crl:WI (Han) rats (8-10 weeks of age; Charles River Laboratories, Germany) as previously described [74,75; cf. Subsection 2.3.1 for the description of the animal facilities]. Ten freshly prepared PCLuS per well were transferred to a 6-well plate containing DMEM/F-12 and incubated with the test material for 24 h. Again, 15 nm-SiO 2 or 55 nm-SiO 2 were applied at test substance concentrations up to 600 g/mL.
For the alkaline Comet assay, the necessary single cell suspensions of the treated PCLuS were prepared applying a modified mincing method [76] . The PCLuS were transferred to new 6-well plates, and each well was filled with 2.5 mL cold (4 • C) mincing solution (Hanks' balanced salt solution (HBSS) without Ca 2+ or Mg 2+ containing 50 mM EDTA and 10% DMSO; adjusted to pH 7.5). The 6-well plates were shaken about 60 s on a plate shaker, and after repeated washing of each well, the residual solution was removed. PCLuS were carefully transferred into a micro test tube filled with 1 mL cold mincing solution. The PCLuS were cut into small pieces with a pair of scissors, and single cell suspensions were prepared by passing the tissue pieces gently through a cell filter (100 m pore size). The obtained single cell suspension was transferred into a 15 mL centrifuge tube and filled up to 5 mL with cold centrifugation buffer (HBSS with Ca 2+ or Mg 2+ supplemented with 5% FCS). The cells were pelleted by centrifugation at 250 g for 5 min (4 • C). The supernatant was carefully removed, and the pellet was re-suspended in 100 L cold centrifugation buffer and stored on ice. The subsequent alkaline Comet assay was carried out using the standard operating procedure (cf. Subsection 2.2.1).
2.2.3.
Alkaline unwinding assay and colony formation assay 2.2.3.1. Cell treatment and preparation. The Alkaline unwinding assay was performed with A549 cells treated with 0, 10, 50, 100 or 300 g/mL 9 nm-SiO 2 , 15 nm-SiO 2 , 30 nm-SiO 2 , or 55 nm-SiO 2 or with V79 cells treated with the same concentrations of 15 nm-SiO 2 or 55 nm-SiO 2 applying the methodology described by Hartwig et al. [55] .
The A549 cells (ATCC, Germany) were cultured as monolayers in DMEM supplemented with 10% FCS (in the following: DMEM + FCS) and 1% penicillin/streptomycin (10.000 IU/10.000 mg/mL) achieving cell confluence of at least 50% on the basis of a doubling time 22 h. The V79 cells were cultured as described under Subsection 2.2.1.1. All cell cultures were incubated under standard cell culture conditions. During their logarithmic growth phase, A549 or V79 cells were incubated with the respective test material for 24 h. Afterwards, the culture medium was removed, the cells were washed with cold PBS, and lysis buffer was added (0.006 M Na 2 HPO 4 , 0.001 M KH 2 PO 4 , 0.137 M NaCl, 0.003 M KCl and 0.1% Triton X-100). After 5 min incubation on ice in the dark, the solution was removed, and the cells were treated with a high salt solution (2 M NaCl, 0.01 M EDTA and 0.002 M Tris; pH 8.0) on ice for 2 min. After removing this solution as well, the cells were left on ice for an additional 8 min.
2.2.3.2. Detection of DNA strand breaks or Fpg-sensitive sites. The samples were incubated for 30 min with or without 1 g/mL Fpg in enzyme buffer (0.05 M sodium phosphate, 0.01 M EDTA, 0.1 M NaCl, pH 7.5) at 37 • C. At the end of the incubation, an alkaline solution (pH 12.3) was added to the samples to achieve final concentrations of 0.07 M NaOH, 0.013 M EDTA, and 0.37 M NaCl. The DNA was allowed to unwind at room temperature for 30 min in the dark, and subsequently, the solution was neutralized with HCl, sonicated on ice, and SDS was added to a final concentration of 0.05%. Singleand double-stranded DNA were separated on 1 mL hydroxyapatite columns by successive elution with 0.15 M and 0.35 M potassium phosphate buffer at 60 • C. The DNA contents of both fractions were determined by adding Hoechst 33258 nucleic acid stain (final concentration of 7.5 × 10 −7 M) to each sample and measuring fluorescence with a microtiter fluorescence reader (Infinite F200 PRO, Tecan, Switzerland; 360 nm excitation wavelength and 455 nm emission wavelength). The fraction of double-stranded DNA and lesion frequencies were calculated as described by Hartwig et al. [55] . Steady state levels of Fpg-sensitive sites were derived from control cells. Test results were recorded as mean values of at least 6 measurements derived from 3 independent experiments plus standard deviation. Statistical data evaluation was performed by one-way ANOVA followed by Dunnett's T-test using the SPSS statistics 21.0 software for Windows. Positive results were considered to be biologically relevant if the corresponding NC value was exceeded by a factor of 2 or more and if effects were dose-dependent.
2.2.3.3.
Concomitant colony formation assay. The colony formation assay was performed with logarithmically growing A549 or V79 cells treated with up to 300 g/mL 15 nm-SiO 2 or 55 nm-SiO 2 (and, additionally, 9 nm-SiO 2 or 30 nm-SiO 2 for the A549 cells). After the 24-h incubation period, the cells were washed with PBS, trypsinized, and counted. To assess the impact of the test substance on cellular colony forming ability (CFA), 300 cells/dish were seeded in fresh MEM or DMEM, for the V79 and A549 cells, respectively. After 7-10 days of incubation, colonies were fixed with ethanol, stained with Giemsa dye, counted and calculated relative to the corresponding control values.
In vivo tests 2.3.1. Animals
Male Wistar rats Crl:WI(Han) (specific pathogen free; about 7 weeks of age) were obtained from Charles River Laboratories (Sulzfeld, Germany) allowing for an acclimatization period of 6 days before the onset of the study. The BASF SE animal facility, in which the in vivo studies were performed and the PCLuS were prepared, holds a certificate from the International Association for Assessment and Accreditation of Laboratory Animal Care. Permission for all animal work was obtained from the local regulatory agencies, and all study protocols complied with the Federal and European legal provisions guidelines. Each dose group consisted of eight animals.
Instillation of test material
15 nm-SiO 2 or 55 nm-SiO 2 dispersions were administered to the rats by single intratracheal instillation (500 L bolus dose containing 360 g test material in saline solution) under deep isoflurane anesthesia (Isoba ® , Essex GmbH, Munich, Germany). This dose corresponds to the expected deposition of 10 mg/m 3 in a rat shortterm inhalation study (STIS; [63] ) where this concentration did not elicit any adverse effects upon 5-day exposure (6 h/day) apart from minimal increases in the polymorphonuclear granulocytes in the BALF (data not shown). The concurrent control animals were instilled with 500 L saline solution. Body weight of the animals was assessed before instillation and on the day before gross necropsy.
Bronchoalveolar lavage
Three days (72 h) after instillation, blood samples from 5 animals per group were collected after overnight food withdrawal using retro-orbital venipuncture under isofluorane anesthesia. The animals were euthanized (100 mg/kg bw pentobarbital; Narcoren ® , Merial, Hallbergmoos, Germany), and blood was sampled by exsanguination from the abdominal aorta and vena cava. BALF was collected from these 5 animals per group by flushing the lungs twice with 5 mL saline at room temperature at a flow rate of 12 mL/min. Subsequently, the animals were prepared for the genotoxicity assays, necropsy, and histopathological evaluations.
BALF analysis and hematology
The following parameters were determined in the BALF: total protein, enzyme activities and total and differential cell counts. Total protein was measured according to the method described by Iwata and Nishikaze [77] and Luxton et al. [78] using benzethonium chloride. The activities of lactate dehydrogenase, alkaline phosphatase, ␥-glutamyltransferase, and N-acetyl-␤-glucosaminidase were determined with a Hitachi 917 reaction rate analyzer (Roche Diagnostics, Mannheim, Germany). Total cell counts were determined using an ADVIA 120 hematology analyzer (Siemens Diagnostics, Fernwald, Germany). Differential cell counts were assessed microscopically according to the method described by Warheit et al. [79, 80] , counting 400 cells per slide.
The ADVIA 120 analyzer was also used to measure blood parameters, i.e. red blood cells, platelets, hematocrit, hemoglobin, and total leucocytes. Again, differential cell count was determined microscopically. Additionally, the acute phase proteins haptoglobin and ␣ 2 -macroglobulin were quantified. Haptoglobin was determined photometrically using the Hitachi 917 instrument (Roche Diagnostics, Mannheim, Germany) based on preservation of peroxidase activity (Tridelta Ltd., Maynooth, Ireland), and ␣ 2 -macroglobulin was determined using an ELISA kit system (Kamiya Biomedical Co., Seattle, USA) with photometric detection (Sunrise MTP Reader, Tecan AG, Männedorf, Switzerland) using the Magellan software provided by the supplier. The BALF cytology and enzyme data and the serum hematology and acute phase protein data were subjected to non-parametric one-way analysis using the Kruskal-Wallis test. If the resulting p value was ≤0.05, or if only one group was compared to the controls a pairwise comparison of each dose group with the control group was performed using the Wilcoxon test (two-sided).
Gross necropsy and histopathology
Also three days after instillation, three animals per group were submitted to gross necropsy and histopathology. Absolute and relative organ weights of lung, kidney, liver, spleen and thymus were assessed. For histopathological evaluation, HematoxylinEosin-stained sections of the nasal cavity, larynx, trachea, lung, mediastinal lymph nodes, and spleen were evaluated by light microscopy. Additionally, ultrathin sections (70 nm) of the spleen were subjected to transmission electron microscopy (TEM), after semi-thin (500 nm) sectioning and staining as described by Morfeld et al. [81] .
Alkaline Comet assay in in vivo lung cells
The in vivo mammalian alkaline Comet assay was performed in accordance with the protocol from the Japanese Centre for the Validation of Alternative Methods [82] . After collection of BALF from 5 animals per group lung lobes were prepared. Cells were isolated from the lungs (as the primary target organ upon intratracheal instillation) of the lavaged animals applying the mincing process described in Subsection 2.2.2 with the following modifications: lungs were washed in 10 mL mincing solution and then transferred to vessels filled with 4 mL mincing solution; tissue pieces obtained by mincing with a pair of scissors were gently forced through filters with pore sizes of 73 m, and cell pellets were re-suspended in 3-5 mL cold centrifugation buffer. The alkaline Comet assay and the concomitant trypan blue exclusion assay were performed as described in Subsection 2.2.1. In vivo cell suspensions were assessed as being of adequate quality if at least 60% of the isolated cells were viable in the trypan blue exclusion assay. Test results were expressed as mean per test group (5 animals each, except for 3 animals in the EMS test group) and standard deviation. Per animal 50 images on two slides each were scored.
Effects were considered positive if the mean% tail DNA of the respective test group exceeded the concurrent mean NC value by at least a factor of two and was above 15% tail DNA. This value was set based on an in-house NC (vehicle control) database (n = 18 animals) [83] . The Student's t-test (p ≤ 0.05) was performed to assess statistical significance.
Micronucleus test in in vivo bone marrow cells
The in vivo mammalian erythrocyte micronucleus test (MNT) was conducted according to OECD TG 474 [84] to assess aneugenic effects (alterations of chromosome numbers) or clastogenic effects (chromosome breakage) in immature bone marrow erythrocytes.
From the same 5 animals per test group from which lung lobes were prepared for the Comet assay the femora were taken to obtain bone marrow cells. These cells were isolated according to the method described by Schmid [85] and Salamone et al. [86] . Immediately after cutting off the epiphyses, the diaphyses of the bone marrow were flushed using a cannula filled with preheated (37 • C) FCS. Based on a method from Romagna and Staniforth [87] , nucleated cells were eluted by filtering the bone marrow cell suspension through a cellulose column using HBSS. After centrifugation at 300 g for 5 min, the obtained cell pellet was re-suspended in 50 L FCS and layered on a microscopic slide. The slides were air-dried, stained with modified May-Grünwald solution and mounted in Eukitt ® medium (Corbit Balsam).
A sample of 2000 polychromatic erythrocytes (PCE) was scored per animal (10,000 PCE per test group) for the occurrence of micronuclei. The number of normochromatic erythrocytes (NCE) was counted in parallel to calculate the ratio of PCE to NCE. An alteration of this ratio indicates that the test substance reached the bone marrow and affected erythropoiesis. Test results were expressed as mean per test group (5 animals each) and standard deviation.
Findings were assessed as positive, if the number of PCE containing micronuclei was significantly increased (one-sided Wilcoxon test; *p ≤ 0.05) and the number of PCE containing micronuclei exceeded the concurrent NC values by at least a factor of two, jointly considering biological relevance and statistical significance [88] [89] [90] .
Results

Test substance characterization
In their as-supplied suspensions, 9 nm-SiO 2 , 15 nm-SiO 2 , 30 nmSiO 2 and 55 nm-SiO 2 had these respective particle sizes in mono-disperse form (Table 1) . Dispersed in protein-free F-12K medium, the test substances displayed a broader size distribution and mass-average diameters of 13 nm, 21 nm, 47 nm, and 87 nm, respectively (Table 1 ). In 0.9% NaCl solution, mass-average particle sizes of 52 nm and 142 nm were recorded for 15 nm-SiO 2 and 55 nm-SiO 2 , respectively (Table 1 and Fig. 1 ). Hence, both 15 nm-SiO 2 and 55 nm-SiO 2 were only marginally agglomerated in physiological salt buffer, with similar Average Agglomeration Numbers (AAN) around 3. However, 15 nm-SiO 2 and 55 nm-SiO 2 strongly agglomerated in cell culture medium supplemented with protein-containing serum. Furthermore, as assessed by standard AUC evaluation, both materials reached nearly identical diameters of 703 nm and 609 nm, respectively. These results are corrected to about 1800 nm and about 3200 nm agglomerate diameter, respectively, by an advanced evaluation that reflects the fractal geometry of nanoparticle agglomerates [54] . In summary, in protein-containing medium the smaller primary particles of 15 nm-SiO 2 agglomerate to at least the same, most probably even significantly larger agglomerate sizes than the larger primary particles of 55 nm-SiO 2 . For both materials, no freely dispersed particles can be detected in DMEM + FCS medium, although the technique is validated to quantify traces of SiO 2 particles down to 50 ppm even in the presence of large agglomerates [54, 91] .
Whereas the majority of the characterization data are available for 15 nm-SiO 2 , the surface interaction data determined by Schaefer et al. [91] underline that the surface chemistry of 55 nm-SiO 2 is very similar, both in water and in culture media. Overall, all Levasil ® types exhibit high surface energy and pronounced hydrophilicity, with surface silanols inducing the polar particle surface [91, 92] .
Calculation of in vitro and in vivo effective dosages
Using the ISDD model [57] and the agglomerate diameters that were experimentally determined by sedimentation (AUC standard evaluation, cf. Section 3.1), the following in vitro effective dosages were calculated, i.e. the proportion of the applied NM expected to reach the cultured cells within an incubation period of 12 or 24 h:
• 15 nm-SiO 2 in DMEM + FCS: 31% after 12 h; 43 % after 24 h.
• 55 nm-SiO 2 in DMEM + FCS: 41% after 12 h; 63% after 24 h.
At test substance concentrations of 300 g/mL, i.e. the highest dosage not inducing pronounced cytotoxicity in the alkaline Comet assay or Alkaline unwinding assay at a given filling height of the cell culture vessels, the fractions of the amorphous SiO 2 NMs in DMEM + FCS amount to the following effective dosages expressed as mass per unit cell culture surface area:
• 15 nm-SiO 2 : 19.4 g/cm 2 after 12 h; 26.9 g/cm 2 after 24 h.
• 55 nm-SiO 2 : 25.6 g/cm 2 after 12 h; 39.4 g/cm 2 after 24 h.
Since MEM and DMEM are very similar culture media, the in vitro effective dosages of 15 nm-SiO 2 and 55 nm-SiO 2 in MEM supplemented with 10% FCS are expected to lie in these same orders of magnitude. Even though DMEM contains a number of amino acids and proteins that are not present in MEM, the protein-rich FCS supplement is expected to elicit the overriding effect on nanoparticle dispersibility. By contrast, the F-12K nutrient supplement applied in the test runs using PCLuS contains fewer proteins than FCS. Since addition of protein-containing media promoted amorphous SiO 2 NM agglomeration (Table 1) , the test substance dispersions prepared with DMEM and F-12K are expected to be less agglomerated than those containing DMEM + FCS so that the corresponding in vitro effective dosages are likely to be lower.
By comparison, in vivo the total representative rat lung surface area at 100% lung capacity is approximately 3000-3500 cm 2 [93, 94] . Assuming even distribution of the test substance prepa- ration in the alveoli (which however does not reflect the situation upon intratracheal instillation), the in vivo bolus dose of 360 g/lung corresponds to 0.10-0.12 g/cm 2 lung surface area. (By comparison, exposing rats to 10 mg/m 3 15 nm-SiO 2 by inhalation for six hours a day on five consecutive days led to a lung burden of 342 g [15] , which is very similar to the bolus dose applied in the present study by intratracheal instillation.)
Based upon these figures, the lowest in vitro test substance concentration of 10 g/mL in DMEM + FCS is still tenfold higher than the calculated in vivo dosage (i.e. in vitro effective dosages after 24 h: 0.9 g/cm 2 for 15 nm-SiO 2 and 1.3 g/cm 2 for 55 nm-SiO 2 ). However, since intratracheal test substance instillation results in alveolar regions with high or low substance deposition, the in vitro effective dosage is likely to reflect alveolar regions exposed to high test substance concentrations.
3.3.
In vitro assays 3.3.1. Alkaline Comet assay in the V79 cell test system Exposure to 55 nm-SiO 2 did not reduce the viability of the exposed V79 cells (assessed in the trypan blue exclusion assay) at any test concentration. 15 nm-SiO 2 did not reduce viability up to test concentrations of 100 g/mL. First signs of cytotoxicity were observed at 300 g/mL 15 nm-SiO 2 (93.7% viability) and higher concentrations of 600 g/mL were clearly cytotoxic (72.0% viability; Fig. 2) . Therefore, the recordings for 600 g/mL 15 nm-SiO 2 and 55 nm-SiO 2 in the V79 cells were excluded from the genotoxicity assessment.
Upon 24-h exposure to V79 cells, both 15 nm-SiO 2 and 55 nmSiO 2 induced small but dose-dependent increases in DNA damage. Relevant (i.e. at least 2-fold compared to the NC) increases in relative tail intensity were observed upon application of 100 and 300 g/mL 15 nm-SiO 2 and 300 g/mL 55 nm-SiO 2 (Fig. 2) . Overall, dose-dependency and the increases in relative tail intensity elicited by 15 nm-SiO 2 were more pronounced than those induced by 55 nm-SiO 2 .
Alkaline Comet Assay in the PCLuS test system
Viability of the suspended cells of the NC (determined by trypan blue exclusion) ranged between 64 and 86% relative to the total cell count. In PCLuS, both 15 nm-SiO 2 and 55 nm-SiO 2 induced a dose-dependent decrease in cell viability up to the highest applied dose of 600 g/mL. Relative cell viabilities below 80% (relative to the NC) were recorded for one measurement of 300 g/mL 15 nmSiO 2 (57.1%; individual values not shown) as well as for 600 g/mL 15 nm-SiO 2 or 55 nm-SiO 2 (mean values: 78.7% and 73.5% of NC, respectively) indicating cytotoxic reactions. Therefore again, the 600 g/mL test substance concentration was precluded from the genotoxicity assessment (Fig. 3) .
In PCLuS, 15 nm-SiO 2 and 55 nm-SiO 2 dose-dependently increased relative tail intensity over the entire concentration range of 10-300 g/mL. In this system, both substances induced low, but relevant effects (≥twofold increase compared to the respective NC) evident at concentrations ≥50 g/mL (Fig. 3) .
Alkaline unwinding assay and colony formation assay
In the colony formation assay performed concomitantly with the Alkaline unwinding assay to evaluate cell viability, 9 nm-SiO 2 , 15 nm-SiO 2 , 30 nm-SiO 2 and 55 nm-SiO 2 elicited slight decreases (i.e. still exceeding 80% relative to the NC) in colony forming ability in A549 cells at 300 g/mL (Fig. 4A-D) . In V79 cells, the highest applied concentration of 300 g/mL 15 nm-SiO 2 and 55 nm-SiO 2 reduced CFA to approximately 50% and 70%, respectively, relative to the NC indicating initial cytotoxic reactions ( Fig. 5A and B) .
In the Alkaline unwinding assay performed with A549 cells, 24-h treatment with 9 nm-SiO 2 , 15 nm-SiO 2 , 30 nm-SiO 2 or 55 nm-SiO 2 dose-dependently induced DNA strand breaks. The effect was particle size-dependent: treatment with 30 nm-SiO 2 and 55 nm-SiO 2 (with larger PPS) resulted in a slight dose-dependent increase in the number of DNA strand breaks, which was significant at 50 g/mL and above. These findings were assessed as biologically relevant since all values were at least twofold the NC value and they occurred in a dose-dependent manner. Fpg-sensitive sites, indicating oxidatively damaged DNA bases, were not significantly increased (Fig. 4C  and D) . Notes: Shown are mean values of at least 6 measurements derived from 3 independent experiments plus standard deviation. Differences statistically significant as compared to control: *p < 0.05, **p < 0.01, ***p < 0.001; determined by one way analysis of variance (ANOVA) followed by Dunnett's T test. Steady state levels of Fpg-sensitive sites were derived from control cells. 9 nm-SiO 2 and 15 nm-SiO 2 (with smaller PPS) only induced statistically significant increases in DNA strand breaks at higher concentrations, i.e. 100 g/mL and above in the case of 9 nm-SiO 2 and 300 g/mL in the case of 15 nm-SiO 2 . 9 nm-SiO 2 and 15 nmSiO 2 further elicited some increase in Fpg-sensitive sites; however, for both compounds this was only significant at 100 g/mL (Fig. 4A  and B) . Since all significant values further exceeded the corresponding NC values by at least a factor of 2, they were assessed as biologically relevant.
In V79 cells, 10-300 g/mL 55 nm-SiO 2 did not induce increases of DNA strand breaks or Fpg-sensitive sites (Fig. 5B) . For 15 nmSiO 2 , a single significant increase in DNA strand breaks, but not Fpg-sensitive sites, was observed at 100 g/mL. Missing effects at 300 g/mL may be due to toxicity (Fig. 5A) . Based upon significance, dose-dependency (as compared to the non-significant value recorded at 50 g/mL), and the extent of increase in DNA strand break rates (that by far exceeded two-fold of the NC), the finding at 100 g/mL 15 nm-SiO 2 was assessed as being biologically relevant.
In vivo tests
Intratracheal instillation of 360 g 15 nm-SiO 2 or 55 nm-SiO 2 did not induce any substance-related clinical findings within the 72-h observation period. Also the mean body weights of the treated animals did not differ from the concurrent NC groups.
Clinical chemistry and hematology
In the BALF of the rats treated with bolus doses of 360 g 15 nm-SiO 2 or 55 nm-SiO 2 , polymorphonuclear neutrophils and lymphocytes were increased 72 h after intratracheal instillation (Fig. 6) . Likewise, total protein and the enzyme activities determined in the BALF were significantly increased (with more pronounced changes elicited by 15 nm-SiO 2 , than by 55 nm-SiO 2 ). These findings were assessed as indicating local pulmonary inflammation. By contrast, all parameters assessed in the blood remained unaltered (data not shown). For animals treated with 55 nmSiO 2 , a statistically significant decrease in thrombocyte counts was detected three days after instillation. Since this finding did not correlate with any other alterations, it was assessed as being incidental and not biologically relevant.
Gross necropsy and histopathology
Intratracheal instillation of bolus doses of 360 g 55 nm-SiO 2 did not affect the absolute or relative weights of the lungs, kidneys, livers, spleens or thymuses of the treated rats (data not shown). By contrast, in the 15 nm-SiO 2 -treated group the absolute weights of the lungs and spleens were increased (138% and 119% of the was without findings, and this observation did not correspond to the recorded weight increase. Possibly, the inflammatory processes in the lungs lead to a slight activation of the spleen that is not yet discernible.
Alkaline Comet assay in in vivo lung cells
For the control animals (n = 5), a mean relative tail intensity of 18.9% ± 2.0 was determined, which was similar to corresponding historical control data for the alkaline Comet assay in different tissues from Wistar rats (data not shown). No relevant genotoxic effects were observed in the lung cells of the 15 nm-SiO 2 -or 55 nmSiO 2 -treated rats (mean relative tail intensities 19.1% ± 6.7 and 12.8% ± 3.6, respectively). Oral application of 300 mg/kg bw EMS, which was used as PC, led to severe DNA damage with significantly increased mean relative tail intensities (78.89% ± 6.32; Fig. 7 ).
Micronucleus test in in vivo bone narrow cells
Mean micronucleus rates of 1.4‰ ± 0.55 were calculated in the bone marrow cells of the NC group. After intratracheal instillation of 360 g 15 nm-SiO 2 or 55 nm-SiO 2 , the micronucleus rates were in the same range, i.e. 1.4‰ ± 0.82 and 1.6‰ ± 0.96, respectively. Likewise, the ratio of PCE to NCE remained unaltered. Hence, neither 15 nm-SiO 2 nor 55 nm-SiO 2 induced aneugenic or clastogenic effects in the in vivo micronucleus test and further did not affect erythropoiesis. By contrast, micronucleus rates were significantly increased (21.9‰ ± 4.9) upon oral administration of 300 mg/kg bw EMS (Fig. 8) .
Summary of test results
In vitro, non-cytotoxic concentrations of 100-300 g/mL 15 nmSiO 2 and 300 g/mL 55 nm-SiO 2 elicited relevant (i.e. 2-fold higher than the NC) DNA damage in the alkaline Comet assay using V79 cells. In the Alkaline unwinding assay performed with V79 cells, only 15 nm-SiO 2 significantly increased DNA strand breaks (and only at 100 g/mL), whereas neither substance (up to 300 g/mL) increased Fpg-sensitive sites. In the alkaline Comet assay using rat PCLuS, both substances induced significant DNA damage at concentrations ≥50 g/mL. In the Alkaline unwinding assay performed with human A549 cells, the larger 30 nm-SiO 2 and 55 nmSiO 2 induced significant increases in DNA strand breaks already at ≥50 g/mL, whereas the smaller 9 nm-SiO 2 and 15 nm-SiO 2 induced significant DNA damage only at higher concentrations. In A549 cells, 9 nm-SiO 2 and 15 nm-SiO 2 further increased Fpgsensitive sites (significant at 100 g/mL). However, all in vitro test substance concentrations are higher than average in vivo dosages, even when applied as intratracheal boluses. In vivo, upon single intratracheal instillation of 360 g into the lungs of rats, neither 15 nm-SiO 2 nor 55 nm-SiO 2 caused genotoxic effects in the lung, the primary target organ, or in the bone marrow. However, pulmonary inflammatory reactions were recorded in both test groups, and these findings were more pronounced in the rats treated with 15 nm-SiO 2 than in those animals treated with 55 nm-SiO 2 .
Discussion
In line with legal requirements to reduce animal testing [95, 96] and since no single assay is capable of detecting all types of mutagenic, aneugenic, or clastogenic effects, genotoxicity testing strategies start out with a battery of in vitro assays and follow on to appropriate in vivo test methods [24, 97, 98] . In vivo assays are performed to rule out false positive results, which are frequently recorded in in vitro genotoxicity assays when assessing non-nanosized conventional substances or NMs [20, 36, 64, 99] . Furthermore, it has been cautioned that also negative outcomes obtained in vitro are not necessarily conclusive, since DNA strand breaks are only one form of DNA damage that a substance may induce [31] . Additionally, in vivo studies include uptake, distribution, and excretion and allow the observation of concurrent general toxic effects thereby enabling a more comprehensive understanding of underlying toxic modes of action [99] .
Specifically for the testing of NM genotoxicity, the lack of nanosized PCs has been addressed as restricting the relevance of test results [100] . It has been recommended to thoroughly characterize NMs that are submitted to genotoxicity tests, to use standardized test methods, to aim at distinguishing different mechanisms of toxicity, also taking into account cellular uptake. It is further important to carefully select appropriate cell models and to avoid assessing genotoxicity at cytotoxic concentrations. Finally, in vitro results should be correlated to in vivo data, considering uptake and distribution [20, 36, 99, 101] .
Fulfilling these recommendations, the present study encompassed a tiered in vitro-in vivo testing strategy, making use of different in vitro assays including rat precision-cut lung slices to quantify DNA damage. With respect to the detection of DNA strand breaks, the Comet and the Alkaline unwinding assays were applied, the latter additionally in combination with the bacterial Fpg to quantify oxidatively induced DNA base modifications. In the second tier of the present study, the in vivo Comet assay and MNT were combined with a rat intratracheal instillation study to reflect respiratory tract exposure as the predominant route of exposure for most NMs and to assess genotoxic effects in the primary target organ lung and the bone marrow, a relevant target organ if test substances become systemically available. Although the present study did not provide any indication that the bone marrow cells were exposed to the test substances, several in vivo studies showed that minor fractions of NMs that are deposited in the lung do translocate to extra-pulmonary tissues including the bone marrow [14, 102] . Therefore, the in vivo alkaline Comet assay using lung cells and the in vivo MNT using bone marrow cells were performed using the same animals to simultaneously investigate possible genotoxic effects at the site of contact and systemically.
Outcome of the in vitro genotoxicity assays
Using Chinese hamster V79 lung fibroblasts, 15 nm-SiO 2 and 55 nm-SiO 2 elicited small but significant increases in DNA damage in the in vitro alkaline Comet assay at non-cytotoxic concentrations. In the Alkaline unwinding assay, these cells only showed biologically relevant amounts of DNA strand breaks upon incubation with 100 g/mL 15-nm SiO 2 and no Fpg-sensitive sites when exposed to either test substance. When the alkaline Comet assay was performed using rat PCLuS instead of V79 cells, 15 nm-SiO 2 and 55 nm-SiO 2 induced slight, but significant DNA damage. Similarly, when the Alkaline unwinding assay was performed with human alveolar epithelial A549 cells instead of V79 cells, significant increases in DNA strand breaks were observed for all four SiO 2 NMs, with the larger 30 nm-SiO 2 and 55 nm-SiO 2 inducing DNA damage at lower concentrations than the smaller 9 nm-SiO 2 and 15 nmSiO 2 . The latter compounds additionally increased the frequency of Fpg-sensitive sites at 100 g/mL. The oxidative damage observed in A549 cells upon treatment with 15 nm-SiO 2 appears to be in line with the outcome of the electron spin resonance (ESR) analysis performed for this test substance since it confirmed surface ROS generating activity (Table 1) . A positive correlation between surface area and ROS formation has previously been described [103, 104] which might explain the observed particle size dependent effects. It has further been cautioned that NMs, including SiO 2 , might interfere with Fpg, thereby leading to an underestimation of oxidative DNA damage [105] .
A549 and V79 cell lines were both originally isolated from the primary target organ lung. Nevertheless, being permanent cell lines, they have lost many of their original characteristics, which could explain cell-type specific differences in the in vitro genotoxicity results. This hypothesis is also supported by the lower susceptibility of V79 cells towards H 2 O 2 -induced DNA single strand breaks as compared to A549 cells (Supplementary information Fig.  SI1 ). Interestingly, using PCLuS, a three-dimensional organotypic tissue culture system that was freshly prepared from the primary target organ of rats, the animal species submitted to the in vivo studies, revealed significant levels of DNA damage upon incubation with 15 nm-SiO 2 and 55 nm-SiO 2 . However, the PCLuS experiments do not allow discerning which specific cell types were affected. Also, the observed effects did not reflect the outcome of the in vivo Comet assay (cf. Section 4.2).
To the best of the authors' knowledge, prior to the present study, rat PCLuS had not yet been applied for NM genotoxicity testing by other groups. Therefore, in addition to 15 nm-SiO 2 and 55 nmSiO 2 investigated in the present study, the authors further assessed the general applicability of this test system for NM genotoxicity testing. For this purpose, four different OECD representative NMs were submitted to the PLCuS alkaline Comet assay, i.e. rutileanatase TiO 2 NM-105, amorphous SiO 2 NM-200, CeO 2 NM-211, and MWCNT NM-400. (The physico-chemical characterization of these substances as delivered and in situ has been published in www.nanogenotox.eu (deliverable 4.1) and Sauer et al. [59, 75] .) Neither compound induced significant levels of DNA damage, indicating that the effects observed in the present study are specific for the respective Levasil ® particles. Since PCLuS comprise all types of pulmonary cells including alveolar macrophages, the specific identification of compromised cell types could serve to further assess the suitability of PCLuS for genotoxic studies.
The findings obtained in the different in vitro genotoxicity assay-test system combinations applied in the present study are inconsistent with regard to the DNA damaging potential of the different amorphous SiO 2 NMs or their potential to induce oxidative DNA damage. Similarly, published data reflect the difficulty of obtaining consistent results on the in vitro genotoxicity of NMs. A number of in vitro genotoxicity studies use representative NMs that have been listed by the OECD Sponsorship Program for the Testing of Manufactured Nanomaterials and that were assigned a NM-number (http://www.oecd.org/science/nanosafety/ and https://ec.europa.eu/jrc/en/scientific-tool/jrc-nanomaterialsrepository). Application of such NMs may serve to improve study comparability [25] . (In the following, NM-x numberings refer to the respective numberings of the OECD representative NMs.) In Comet assays performed using mouse fibroblasts, differently sized amorphous SiO 2 NMs did not induce genotoxicity [28, 34] . No genotoxicity was further observed in in vitro cytokinesis-block micronucleus studies using human peripheral lymphocytes either when treated with up to 1000 g/mL 15 nm-SiO 2 and 55 nm-SiO 2 [32] or when four different amorphous SiO 2 (NM-200, NM-201, NM-202 and NM-203; concentrations up to 1250 g/mL) were applied [40] . Additionally, exposure to fluorescent-red SiO 2 NMs (PPS: 25 nm; supplied as 2.5% aqueous suspensions) did not increase Fpg-sensitive sites in a modified Comet assay performed with Cos-1 monkey kidney fibroblasts [101] .
By contrast, numerous studies report in vitro genotoxicity of amorphous SiO 2 NMs. [60] , just as it was for further SiO 2 NMs (PPS: 10-50 nm, SEM; hydrodynamic diameter: 266 nm) in human peripheral lymphocytes [38] . Also in HT29, HaCaT and A549 cells, amorphous SiO 2 NMs increased ROS generation and induced DNA damage in the Comet assay [33, 35] . Murine RAW264.7 macrophages and A549 cells treated with dense SiO 2 spheres (PPS: 250 or 500 nm, SEM and DLS in water) or mesoporous SiO 2 particles (MCM-41, PPS: 250 nm, SEM and DLS in water) for 4 and 24 h exhibited DNA strand breaks and chromosomal alterations in the Comet assay and MNT [37] . In A549 cells, monodisperse Stöber amorphous SiO 2 NMs (16 nm) slightly induced micronuclei in binucleated cells, whereas 60 and 104 nm SiO 2 NMs did not [29] . Particle number and total surface area appeared to account for micronuclei induction since these parameters correlated with the amplitude of the effect [29] . In a three-dimensional reconstructed human bronchial epithelial tissue model (EpiAirway TM ), unmodified and phosphate-surface functionalized 15 nm-SiO 2 elicited genotoxicity at 50 mg/cm 2 in the alkaline Comet assay, whereas polyethylene glycol-or amino-surface functionalized SiO 2 particles did not [39] . In summary, also previously published in vitro genotoxicity studies addressing amorphous SiO 2 NMs indicate that the outcome of the assays is apparently dependent upon the choice of the test system. At least the observation that fibroblasts appear less sensitive than A549 epithelial cells [28, 34] appears to be in line with the results from the present study for V79 and A549 cells. (In this respect, also the influence of the culture medium on in vitro NM genotoxicity requires further investigation.)
Outcome of the in vivo genotoxicity tests
The results obtained in the in vivo Comet assay and in vivo MNT were unambiguous: in vivo intratracheal instillation of 360 g bolus doses of 15 nm-SiO 2 or 55 nm-SiO 2 into rats did not result in genotoxicity either in the primary target organ lung or in the bone marrow. It has to be considered, however, that lower doses (NMs per surface of the lung or cell monolayer) reached the cells after instillation as compared to the in vitro cell culture studies. In contrast to the apparent lack of in vivo genotoxicity, inflammatory reactions were observed in the lung, and rats treated with 15 nm-SiO 2 developed more pronounced effects than those treated with 55 nm-SiO 2 . However, also secondary genotoxic effects which might be expected due to massive neutrophilic inflammation were not observed, which is in line with previous findings [41, 46] .
A number of parameters have to be taken into account in assessing the biological relevance of findings obtained in intratracheal instillation studies. The lung distribution pattern of the test material upon instillation is less homogenous than upon inhalation. Application by instillation bypasses the upper respiratory tract, and a bolus dose is administered directly into the lung, which does not reflect the common human exposure situation. The increased dose rate of bolus applications might cause adverse effects, such as local inflammation, which would not occur upon inhalation [9, 10, 61, 106] . In spite of these limitations, the in vivo results obtained in the present study are considered relevant, since the pulmonary inflammatory effects observed are consistent with the findings from a rat short-term inhalation study [107] . Additionally, in that inhalation study, the pulmonary inflammatory effects were reversible within 3 weeks.
In assessing the biological relevance of the lack of findings in the in vivo MNT, presumably, only very small proportions of the SiO 2 NMs, if at all, reached the bone marrow, i.e. the target organ in the MNT. In a rat STIS, less than 5% of the inhaled 15 nm-SiO 2 was deposited in the lung, the pulmonary clearance rate was high (pulmonary half life <30 days), and test substances were undetectable in the lung-associated lymph nodes [15] . Accordingly, the outcome of the STIS also does not provide an indication for 15 nmSiO 2 biodistribution to the bone marrow upon inhalation exposure. Furthermore, even when SiO 2 NMs become systemically available (as is reflected by intravenous test substance application resulting in immediate systemic availability of the entire dose), only very low proportions are recorded in the bone marrow and appear to be cleared very quickly also from this organ: two hours after single intravenous administration of 0.5 mg radio-labeled 33 nm-SiO 2 , less than 1% of the test substance was measured in the bone marrow of BALB/c mice, and 87% of this already low organ burden had disappeared within 24 h post-administration [108] . Nevertheless, the findings from Malfatti et al. [108] show that SiO 2 NMs that become systemically available may indeed reach the bone marrow, although only to a very small proportion, which will be even smaller upon intratracheal instillation or inhalation. Consistent with these findings for amorphous SiO 2 NMs, only a small fraction of metal oxide NMs (CeO 2 ) deposited in the lung by instillation was found in extra-pulmonary tissues, and only a small fraction of the extrapulmonary Ce was detected in the bone marrow [102] . Overall, the lack of findings in the in vivo MNT may either point to the low genotoxic potential of the tested amorphous SiO 2 NMs or to their low systemic availability upon inhalation/instillation.
Already the spectrum of published in vivo studies investigating amorphous SiO 2 NM genotoxicity documents that their results are hardly comparable. Downs et al. [32] investigated 15 nm-SiO 2 or 55 nm-SiO 2 in rats in a combined in vivo Comet assay -MNT. In contrast to the present study, the protocol encompassed 3 consecutive intravenous injections (48, 24 , and 4 h before sacrifice). Thus, the chosen route of exposure results in immediate systemic availability of the entire test substance dose. A weak increase in relative DNA damage was recorded in cells from the liver, lung and/or blood (up to 1.7-fold compared to the NC) after injection of 125 mg/kg 55 nmSiO 2 or 50 mg/kg 15 nm-SiO 2 . Additionally, this exposure resulted in 1.5-2.1-fold increases of circulating micronucleated reticulocytes relative to the NC as analyzed by flow cytometry [32] . Effects observed in the Comet assay should be at least twofold higher than the concurrent NC and lie in comparable ranges as the ones induced by the PC in order to be assessed as biologically relevant [82, [88] [89] [90] . Notwithstanding, the different routes of exposure may most likely explain the differences in the observations from Downs et al. and those from the present in vivo tests. Additionally, it has to be considered that DNA damage was determined after 72 h in the present study, as opposed to 4, 24 and 48 h in the study from Downs et al. [32] , providing longer time for repair of DNA strand breaks and Fpg-sensitive sites.
Inhalation studies investigating in vivo genotoxicity of amorphous SiO 2 NMs did not reveal DNA damaging effects: in 1-or 3-day rat inhalation studies, exposure to 1.8 or 86 mg/m 3 amorphous SiO 2 NMs (PPS: 37 or 83 nm; long differential mobility analyzer) did not induce genotoxicity in blood cells, as determined in the micronucleus assay [42] . Also 50 mg/m 3 amino-surface functionalized 15 nm-SiO 2 , upon 5-day inhalation exposure to rats, did not elicit DNA damage in either the alkaline Comet assay performed with lung cells or the MNT performed with bone marrow cells [39] . Upon 13-week inhalation exposure in rats, 50 mg/m 3 Aerosil ® 200 (mass median aerodynamic diameter: 0.81 m) did not induce genotoxicity in the HPRT (hypoxanthine-guanine phosphoribosyltransferase) mutation assay in primary alveolar epithelial cells, even though a massive neutrophilic inflammation evolved [41] .
As a further part of the NANOGENOTOX joint action, Guichard et al. [46] investigated the in vivo genotoxic potential of four amorphous SiO 2 (NM-200-NM-203 from the list of OECD representative NMs; PPS: 18-25 nm; TEM) after intratracheal instillation on 3 consecutive days (48, 24 , and 3 h before sacrifice). Whereas all four SiO 2 NMs induced pulmonary inflammatory reactions, neither BALF nor lung cells showed any relevant DNA damage in the standard or Fpg-modified Comet assay. Both methods were also negative when performed with cells from the bone marrow, blood, liver, kidney, or spleen, and the frequency of micronucleated erythrocytes was also not affected [46] . When 5-20 mg/kg bw SiO 2 NM-203 (the NM with the largest PPS of 25 nm) was injected intravenously into rats on 3 consecutive days, changes in blood hematology and biochemistry were obtained, but again no genotoxicity was recorded in any of the assays or organs mentioned above [46] . Finally, also oral application of 5-20 mg/kg bw SiO 2 NM-200-NM-203 with additional assessment of the colon and duodenum did not distinctly change the negative outcome of the genotoxicity assays [45] .
In an earlier intratracheal instillation study assessing SiO 2 genotoxicity, rats were administered 2 mg Aerosil ® 150 (PPS: 14 nm; agglomerates 300-500 nm; characterization methods not specified) three times at monthly intervals [44] . By using immunohistochemical techniques, several markers of DNA damage were investigated in alveolar lining cells. Significantly enhanced numbers of 8-hydroxy-2 -deoxy-guanosine-positive nuclei along with oxidative damage-related repair activity was detected in the cytoplasm of the cells. Nevertheless, other markers of DNA damage, such as poly(ADP-ribose) or phosphorylated H2AX, were not elevated [44] . Thus, oxidative stress and even oxidative alteration of the nuclear DNA does not appear to be a necessary or a sufficient prerequisite for genotoxic DNA damage, which is in line with other studies [41, 43] .
Comparison of dosage and time in in vitro and in vivo experiments
In assessing the relevance of results from in vitro test methods, it is mandatory to compare the applied in vitro doses to realistic in vivo dosages. Since in vivo bolus applications into the lung result in immediate high dose rates, inflammatory effects on the pulmonary cells are usually more pronounced upon instillation than when test substances are administered by inhalation. However, applying particle suspensions into the lung allows for direct comparisons of applied in vitro and in vivo doses, as has been performed in detail in Section 3.2. The mean in vivo primary particle dose of 0.10-0.12 g/cm 2 that is delivered to the alveolar epithelium may be locally de-or increased due to particle agglomeration and/or uneven distribution, but it may also be decreased due to macrophage uptake. By comparison, the in vitro effective dosages were about 10-fold higher: the lowest tested in vitro concentrations of 10 g/mL corresponded to in vitro effective dosages of 0.9-1.3 g/cm 2 , and first in vitro genotoxic effects were seen at dosages 50-100 times higher than the average in vivo doses (50 or 100 g/mL corresponding to effective in vitro dosages of 6.5-13 g/cm 2 , cf. Section 3.2).
Additionally, it has been questioned whether the typical incubation times applied in in vitro genotoxicity assays that mostly do not exceed 24 h are appropriate for more slowly diffusing NMs [109] . The in vitro effective dose calculations performed in the course of the present study support such considerations, highlighting that less than half of the applied dose of 15 nm-SiO 2 (i.e. 43% in DMEM + FCS) and less than two thirds of the applied dose of 55 nmSiO 2 (i.e. 63% in DMEM + FCS) reached the cultured cells within the 24-h incubation period.
Correlation of in vitro and in vivo effects with material properties
In following up on the question whether genotoxic effects elicited by different SiO 2 NMs of the same core material might be related to specific material properties, such as particle size, it has to be distinguished between PPS and particle size in preparation. In fact, in evaluating the outcome of the in vitro assays, it is unlikely that the four different Levasil ® types reached the in vitro cells with considerably differing hydrodynamic diameters at all. The extensive AUC-based calculations of the test substances dispersed in media (Table 1) revealed that all four test substances agglomerated considerably in protein-containing suspensions and obtained similar hydrodynamic diameters, even though they had differing PPS and hence differing primary specific surface.
However, in the in vitro Alkaline unwinding assay using human A549 cells, which were more sensitive than the V79 cells, 30 nmSiO 2 and 55 nm-SiO 2 (with larger PPS) induced significant increases in DNA strand breaks at lower concentrations than 9 nm-SiO 2 and 15 nm-SiO 2 with smaller PPS. Additionally, these two smaller SiO 2 NMs increased Fpg-sensitive sites, which however was only significant at 100 g/mL. In accordance with this -albeit restricted dataset from four test substances -the potency for DNA damage as such inversely correlated with NM PPS, whereas oxidative DNA damage was only caused by the smaller SiO 2 NMs. Further investigations should aim at assessing whether the higher in vitro effective dosage of 55 nm-SiO 2 (63% in DMEM + FCS) as compared to 15 nmSiO 2 (43% in DMEM + FCS) accounts for the observed differences in in vitro genotoxicity. Additional investigations should also address why a higher in vitro effective dose was calculated for 55 nm-SiO 2 than for 15 nm-SiO 2 , even though their hydrodynamic diameters in biological media were comparable (703 nm and 609 nm, respectively, in DMEM + FCS).
However, 15 nm-SiO 2 and 55 nm-SiO 2 were observed to cause pulmonary effects in vivo upon intratracheal instillation: both substances caused inflammatory reactions in the lung, and these were more pronounced for 15 nm-SiO 2 (that also had a smaller hydrodynamic diameter in 0.9% saline, i.e. 52 nm) than for 55 nm-SiO 2 (that also had a larger hydrodynamic diameter in 0.9% saline, i.e. 142 nm). Accordingly, the SiO 2 NM with the smaller hydrodynamic diameter elicited more pronounced pulmonary inflammation. Further investigations are necessary to elucidate whether this observation points to a size-dependency of the pulmonary inflammatory reactions caused by SiO 2 NMs.
Roller [110] , reviewing published in vitro studies, found almost no influence of particle size on in vitro genotoxicity of NMs. Park et al. [31] observed 80 nm amorphous SiO 2 NMs, but not 10, 30, or 400 nm particles (test substance concentrations 4, 40 or 400 g/mL) to induce chromosome aberrations in the MNT using 3T3-L1 mouse fibroblasts. Yang et al. [111] assumed that NM genotoxicity might be mostly attributed to particle shape, rather than chemical composition, and Klien and Godnic-Cvar [112] suggested that NM genotoxicity might be affected by a variety of parameters, such as particle size, surface modification (particle coating), exposure route, and exposure duration. Specifically for SiO 2 NMs, ROS generating activity and hydrophobicity/hydrophilicity are recognized as predominant parameters affecting cellular toxicity [92] .
As the characterization of material properties undertaken in the present study confirms, surface reactivity and the presence of proteins in the culture media strongly affect NM dispersibility and agglomeration-and hence, most likely also the outcome of in vitro studies. Consistent with these considerations, Gonzalez et al. [30] observed size-dependent micronucleus induction by 16 nm, 60 nm and 104 nm amorphous SiO 2 NMs in the micronucleus cytokinesis-block assay applying A549 cells at non-cytotoxic dosages (0.15-150 g/mL, depending on the type of particle), with larger NMs being more reactive in the absence of serum.
Up until now, the complexity of nanostructure-activity relationships precludes the establishment of the exact correlation of a single material property of any given NM and its toxicity [48, [113] [114] [115] [116] [117] . In an extensive review of SiO 2 toxicology, FruijtierPölloth [6] concludes that the biological activity of amorphous SiO 2 NMs may be related to the particle shape and surface characteristics interfacing with the biological milieu rather than to particle size. Notwithstanding, Gonzalez et al. [29] advise taking into account particle size in NM genotoxicity testing, since this parameter affects diffusion and gravity-driven sedimentation that determine the effective in vitro dose together with size-dependent cellular uptake kinetics.
Conclusions
The results of the present study add further evidence that genotoxicity of SiO 2 NM is material-and cell type-dependent and not consistently detected in all in vitro systems. However, more pronounced effects were observed in PCLuS freshly prepared from the rat lung than in the in vitro single-cell type cultures. Nevertheless, animal studies with intratracheal instillation of high bolus doses did not elicit genotoxicity in the in vivo Comet assay in lung cells or in the in vivo MNT in bone marrow erythrocytes. This may be explained by the fact that a considerably lower dose (mass of NM per lung surface area) reached the target cells in the in vivo instillation studies than in the in vitro assays. Additionally, the different time points of investigation may account for differences between the in vitro and in vivo effects, providing more time for repair of DNA damage after instillation. In regard to the applicability of in vitro genotoxicity assays, either as initial tiers in integrated testing strategies or even as stand-alone methods, however, the outcome of the present study highlights difficulties in reliably predicting in vivo effects from the outcome of in vitro studies.
NMs should not per se be considered in vivo genotoxins if in vitro effects are observed at doses which are not reached in vivo. These genotoxic effects observed in vitro, but not in vivo, however, indicate a general potential to induce DNA. Similarly, pro-inflammatory reactions that are observed in vitro may indicate in vivo inflammatory reactions if the selected test systems, endpoints and test substance concentrations are relevant for the in vivo situation [25] . Further investigations are necessary to determine relevant in vitro genotoxicity test systems that adequately reflect the in vivo situation, just as to determine relevant protocols for test substance preparation to ensure that NMs are applied in a form in vitro that reflects the in vivo situation. In this respect also the effective dosage reaching cells in vitro needs to be addressed, just as relevant exposure periods ensuring that the applied test materials truly reach the test system.
